Gallagher Cam
CIK 0001557832 Name as filed on the most recent filing
Filed as Gallagher Cam (43)
138 transaction lines · from 43 filings · filed 2020-11-25 to 2025-12-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
138 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-12-29 |
Opus Genetics, Inc. IRD |
P, Open-market purchase | 83,000 acquired | 1.97 | 163,418.70 | Form 4, filing 0000905148-25-004511 | |
| 2025-12-29 |
Opus Genetics, Inc. IRD |
P, Open-market purchase | 81,000 acquired | 1.98 | 160,274.70 | Form 4, filing 0000905148-25-004511 | |
| 2024-05-31 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 9,597 disposed | 11.98 | 114,972.06 | Form 4, filing 0001725160-24-000127 | |
| 2024-02-12 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,173 disposed | 11.44 | 13,419.12 | Form 4, filing 0001725160-24-000041 | |
| 2024-02-02 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 11,552 disposed | 11.54 | 133,310.08 | Form 4, filing 0001725160-24-000030 | |
| 2023-05-31 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 18,526 disposed | 26.21 | 485,527.56 | Form 4, filing 0001725160-23-000125 | |
| 2023-05-31 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 9,242 disposed | 26.40 | 243,978.63 | Form 4, filing 0001725160-23-000125 | |
| 2023-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 8,501 disposed | 19.96 | 169,706.31 | Form 4, filing 0001725160-23-000033 | |
| 2023-02-13 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,332 disposed | 20.42 | 68,054.10 | Form 4, filing 0001725160-23-000033 | |
| 2023-02-06 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 9,428 disposed | 22.22 | 209,502.42 | Form 4, filing 0001725160-23-000022 | |
| 2023-02-06 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 572 disposed | 23.04 | 13,176.08 | Form 4, filing 0001725160-23-000022 | |
| 2023-01-17 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 9,500 disposed | 24.11 | 229,081.10 | Form 4, filing 0001725160-23-000008 | |
| 2023-01-17 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 500 disposed | 24.87 | 12,433.60 | Form 4, filing 0001725160-23-000008 | |
| 2023-01-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 9,700 disposed | 21.01 | 203,791.18 | Form 4, filing 0001725160-23-000002 | |
| 2023-01-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 300 disposed | 21.46 | 6,437.01 | Form 4, filing 0001725160-23-000002 | |
| 2022-11-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 11,600 disposed | 22.72 | 263,552.00 | Form 4, filing 0001725160-22-000202 | |
| 2022-11-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 900 disposed | 23.48 | 21,131.10 | Form 4, filing 0001725160-22-000202 | |
| 2022-11-08 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 12,374 disposed | 23.56 | 291,542.58 | Form 4, filing 0001725160-22-000194 | |
| 2022-11-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 12,343 disposed | 23.66 | 292,055.13 | Form 4, filing 0001725160-22-000194 | |
| 2022-11-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 157 disposed | 24.24 | 3,805.27 | Form 4, filing 0001725160-22-000194 | |
| 2022-10-17 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 12,500 disposed | 23.51 | 293,878.75 | Form 4, filing 0001725160-22-000184 | |
| 2022-10-06 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 10,000 disposed | 22.62 | 226,180.00 | Form 4, filing 0001725160-22-000182 | |
| 2022-10-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 7,004 disposed | 21.92 | 153,528.38 | Form 4, filing 0001725160-22-000182 | |
| 2022-10-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,496 disposed | 22.83 | 125,478.08 | Form 4, filing 0001725160-22-000182 | |
| 2022-09-16 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 8,866 disposed | 24.38 | 216,158.40 | Form 4, filing 0001725160-22-000167 | |
| 2022-09-16 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,134 disposed | 24.99 | 28,338.43 | Form 4, filing 0001725160-22-000167 | |
| 2022-09-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 8,426 disposed | 25.10 | 211,517.04 | Form 4, filing 0001725160-22-000167 | |
| 2022-09-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,074 disposed | 25.59 | 104,239.81 | Form 4, filing 0001725160-22-000167 | |
| 2022-04-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,369 disposed | 49.72 | 217,206.15 | Form 4, filing 0001725160-22-000067 | |
| 2022-04-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,335 disposed | 50.68 | 169,009.46 | Form 4, filing 0001725160-22-000067 | |
| 2022-04-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,196 disposed | 51.59 | 113,283.08 | Form 4, filing 0001725160-22-000067 | |
| 2022-04-05 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 100 disposed | 52.70 | 5,270.00 | Form 4, filing 0001725160-22-000067 | |
| 2022-03-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,322 disposed | 42.31 | 225,177.55 | Form 4, filing 0001725160-22-000061 | |
| 2022-03-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,578 disposed | 41.45 | 189,745.74 | Form 4, filing 0001725160-22-000061 | |
| 2022-03-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 100 disposed | 43.18 | 4,318.00 | Form 4, filing 0001725160-22-000061 | |
| 2022-03-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 9,477 disposed | 44.90 | 425,559.00 | Form 4, filing 0001725160-22-000057 | |
| 2022-03-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 523 disposed | 45.56 | 23,828.25 | Form 4, filing 0001725160-22-000057 | |
| 2022-02-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 5,366 disposed | 52.15 | 279,852.46 | Form 4, filing 0001725160-22-000038 | |
| 2022-02-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,264 disposed | 51.22 | 167,192.52 | Form 4, filing 0001725160-22-000038 | |
| 2022-02-15 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,370 disposed | 52.74 | 72,249.69 | Form 4, filing 0001725160-22-000038 | |
| 2022-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 4,850 disposed | 50.17 | 243,340.02 | Form 4, filing 0001725160-22-000032 | |
| 2022-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,079 disposed | 50.16 | 104,291.37 | Form 4, filing 0001725160-22-000032 | |
| 2022-02-14 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 259 disposed | 50.75 | 13,143.52 | Form 4, filing 0001725160-22-000032 | |
| 2022-02-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 6,460 disposed | 53.51 | 345,686.23 | Form 4, filing 0001725160-22-000019 | |
| 2022-02-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 2,290 disposed | 52.77 | 120,847.19 | Form 4, filing 0001725160-22-000019 | |
| 2022-02-07 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,250 disposed | 54.35 | 67,940.50 | Form 4, filing 0001725160-22-000019 | |
| 2022-01-18 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,434 disposed | 61.71 | 211,900.46 | Form 4, filing 0001725160-22-000011 | |
| 2022-01-18 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 3,424 disposed | 62.37 | 213,544.61 | Form 4, filing 0001725160-22-000011 | |
| 2022-01-18 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,842 disposed | 63.45 | 116,868.64 | Form 4, filing 0001725160-22-000011 | |
| 2022-01-18 |
Zentalis Pharmaceuticals, Inc. ZNTL |
S, Open-market sale | 1,300 disposed | 64.66 | 84,062.03 | Form 4, filing 0001725160-22-000011 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 3
- Open-market sale 135
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Gallagher Cam, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001557832
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6